CHM chimeric therapeutics limited

Stunning presentation. Looks like massive delays with the GBM...

  1. 1,720 Posts.
    lightbulb Created with Sketch. 540
    Stunning presentation.

    Looks like massive delays with the GBM trial. Reworking the whole design to include IV delivery for first dose and adding in chemo.

    Disappointed we won't see any further GBM results for a long time (probably 2026), especially since the data to date has been so compelling.

    CDH17 now officially the lead candidate. The cohort patient numbers are not at all clear. I take it 15 patients is all dose escalation. And then dose expansion - will they make up the phase 2 patient numbers?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $9.068M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
19 12882293 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 17149687 17
View Market Depth
Last trade - 12.52pm 02/07/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.